CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (15,638)	$ (12,389)
Adjustments to reconcile loss to net cash used in operating activities:
Cost of stock-based payments	3,485	1,225
Changes in operating assets and liabilities:
(Increase)/decrease in other current assets	209	(1,135)
(Decrease)/increase in accounts payable, accrued compensation and benefits, and accrued liabilities	(160)	2,256
Net cash used in operating activities	(12,104)	(10,043)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common shares - At-the market offering	4,388
Issuance costs related to At-the-market offering	(190)
Proceeds from issuance of common stock upon initial public offering		16,000
Issuance costs related to initial public offering	(341)	(2,551)
Proceeds from issuance of common stock and pre-funded warrants in private placement		15,879
Proceeds from exercise of warrants/options/preferred investment option	11,192
Issuance costs related to the exercise of warrants/preferred investment option	(371)
Issuance costs related to private placement	(508)	(1,387)
Net cash provided by financing activities	14,170	27,941
INCREASE IN CASH AND CASH EQUIVALENTS	2,066	17,898
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	19,993	5,742
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$ 22,059	23,640
Supplemental noncash disclosure of investing and financing activities:
Unpaid issuance costs related to the private placement		$ 300